WO1997026893A1 - Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid - Google Patents
Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid Download PDFInfo
- Publication number
- WO1997026893A1 WO1997026893A1 PCT/IB1997/000136 IB9700136W WO9726893A1 WO 1997026893 A1 WO1997026893 A1 WO 1997026893A1 IB 9700136 W IB9700136 W IB 9700136W WO 9726893 A1 WO9726893 A1 WO 9726893A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- alanine
- present
- amount ranging
- nicotinic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU15550/97A AU711536B2 (en) | 1996-01-24 | 1997-01-22 | Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid |
CA 2244132 CA2244132A1 (en) | 1996-01-24 | 1997-01-22 | Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid |
EP97901751A EP0877617A1 (en) | 1996-01-24 | 1997-01-22 | Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1051796P | 1996-01-24 | 1996-01-24 | |
US60/010,517 | 1996-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997026893A1 true WO1997026893A1 (en) | 1997-07-31 |
Family
ID=21746120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1997/000136 WO1997026893A1 (en) | 1996-01-24 | 1997-01-22 | Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid |
Country Status (5)
Country | Link |
---|---|
US (1) | US6071888A (en) |
EP (1) | EP0877617A1 (en) |
AU (1) | AU711536B2 (en) |
CZ (1) | CZ235798A3 (en) |
WO (1) | WO1997026893A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1015472A1 (en) * | 1997-09-11 | 2000-07-05 | Oxigene, Inc. | Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
US6255291B1 (en) * | 1997-03-04 | 2001-07-03 | Peregrine Pharmaceuticals, Inc. | Composition and method for treating cancer and immunological disorders resulting in chronic conditions |
GB2364642B (en) * | 2000-01-07 | 2004-10-27 | Bioenergy Inc | Compositions for enhancing the immune response |
DE102010045185A1 (en) * | 2010-09-13 | 2012-03-15 | Marianne Broendlund | Mixture, use and solution for infusion |
US9404126B2 (en) | 2006-06-12 | 2016-08-02 | Kuros Biosciences Ag | Processes for packaging aggregated oligonucleotides into virus-like particles of RNA bacteriophages |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7504376B2 (en) * | 1996-08-12 | 2009-03-17 | Natural Alternatives International | Methods and compositions for increasing the anaerobic working capacity in tissues |
US5965596A (en) | 1997-08-12 | 1999-10-12 | Harris; Roger | Methods and compositions for increasing the anaerobic working capacity in tissue |
EP1143954B1 (en) * | 1998-12-01 | 2004-08-11 | University of Kentucky Research Foundation | Use of nicotinic acid derivatives for the treatment of dna damage in skin cells |
US20040127428A1 (en) * | 2002-12-28 | 2004-07-01 | Kenyon Keith E. | Use of D-ribose, including as a topical vehicle, to promote faster healing, including from surgical procedures |
US20050152862A1 (en) * | 2003-10-29 | 2005-07-14 | L'oreal | Cosmetic peeling method |
FR2861595B1 (en) * | 2003-10-29 | 2008-07-04 | Oreal | PEELING COMPOSITION COMPRISING VITAMIN B3 AND VITAMIN C |
DK3081215T3 (en) | 2005-05-23 | 2020-04-27 | Natural Alternatives Int Inc | COMPOSITIONS AND PROCEDURES FOR LONG-TERM RELEASE OF BETA-ALANINE |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2609893A1 (en) * | 1987-01-26 | 1988-07-29 | Rougereau Andre | COMPOSITION BASED ON AMINO ACIDS AND VITAMINS FOR USE IN CANCEROLOGICAL THERAPEUTICS |
WO1995002398A1 (en) * | 1993-07-12 | 1995-01-26 | Aliatros Medical A.S. | Pharmaceutical composition for immunomodulating and adjuvant treatment |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4582807A (en) * | 1982-07-30 | 1986-04-15 | Natteri Veeraraghavan | Cultivation medium for mycobacteria and use thereof |
-
1997
- 1997-01-22 CZ CZ982357A patent/CZ235798A3/en unknown
- 1997-01-22 EP EP97901751A patent/EP0877617A1/en not_active Withdrawn
- 1997-01-22 AU AU15550/97A patent/AU711536B2/en not_active Ceased
- 1997-01-22 US US08/787,209 patent/US6071888A/en not_active Expired - Fee Related
- 1997-01-22 WO PCT/IB1997/000136 patent/WO1997026893A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2609893A1 (en) * | 1987-01-26 | 1988-07-29 | Rougereau Andre | COMPOSITION BASED ON AMINO ACIDS AND VITAMINS FOR USE IN CANCEROLOGICAL THERAPEUTICS |
WO1995002398A1 (en) * | 1993-07-12 | 1995-01-26 | Aliatros Medical A.S. | Pharmaceutical composition for immunomodulating and adjuvant treatment |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6255291B1 (en) * | 1997-03-04 | 2001-07-03 | Peregrine Pharmaceuticals, Inc. | Composition and method for treating cancer and immunological disorders resulting in chronic conditions |
EP1015472A1 (en) * | 1997-09-11 | 2000-07-05 | Oxigene, Inc. | Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
EP1015472A4 (en) * | 1997-09-11 | 2004-12-08 | Oxigene Inc | Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
GB2364642B (en) * | 2000-01-07 | 2004-10-27 | Bioenergy Inc | Compositions for enhancing the immune response |
US9404126B2 (en) | 2006-06-12 | 2016-08-02 | Kuros Biosciences Ag | Processes for packaging aggregated oligonucleotides into virus-like particles of RNA bacteriophages |
DE102010045185A1 (en) * | 2010-09-13 | 2012-03-15 | Marianne Broendlund | Mixture, use and solution for infusion |
Also Published As
Publication number | Publication date |
---|---|
US6071888A (en) | 2000-06-06 |
EP0877617A1 (en) | 1998-11-18 |
CZ235798A3 (en) | 1999-03-17 |
AU711536B2 (en) | 1999-10-14 |
AU1555097A (en) | 1997-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4815446A (en) | Process for treating metastasis of cancerous tumors | |
Klimberg et al. | Glutamine, cancer, and its therapy | |
EP0279379B1 (en) | Interstitial administration of perfluorchemical emulsions for reoxygenation of hypoxic tumor cells | |
EP0167263B1 (en) | Drug-containing matrices for introduction into cellular lesion areas | |
US6071888A (en) | Composition for treating cancer | |
US6063814A (en) | Phorbol esters as anti-neoplastic and white blood cell elevating agents | |
US6255291B1 (en) | Composition and method for treating cancer and immunological disorders resulting in chronic conditions | |
JPH06505231A (en) | Use of quinones in the treatment of cancer or AIDS | |
Pierson et al. | Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma | |
HRP980095A2 (en) | Method of treating a tumor | |
JPS63145229A (en) | Vitamin b6-containing medicinal composition | |
JP5553306B2 (en) | Radiation protection agent | |
CA2244132A1 (en) | Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid | |
Aliu et al. | Isometamidium-dextran complex: toxicity and activity against Trypanosoma vivax and Trypanosoma congolense in rats and mice | |
EP0392662B1 (en) | Use of complexes of tetrachloroplatinate with a diazo dye as antitumour agents | |
HUT77652A (en) | Pharmaceutical composition for immunomodulating and adjuvant treatment | |
JP2004315470A (en) | Pharmaceutical preparation containing sodium iodide | |
Rumley Jr et al. | Value of nutritional support in adult cancer patients | |
Houghton et al. | Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts | |
RU2122331C1 (en) | Method of young stock pigs feeding | |
Tannock | Adriamycin: Effects on aerobic and hypoxic cells of the 16C tumor and interaction with misonidazole | |
RU2161486C2 (en) | Method of treatment of patients with radiation-thermal damage and agent for its realization | |
Monge et al. | Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: thermotolerant tumours | |
WO1992008460A1 (en) | Bis-dioxopiperazines for treating liver tumours | |
Shackelford et al. | Preliminary report on the use of zinc in vivo to protect against nitrogen mustard toxicity in female Balb/cJ mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997901751 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2244132 Country of ref document: CA Ref country code: CA Ref document number: 2244132 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1998-2357 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1997901751 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97526701 Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: PV1998-2357 Country of ref document: CZ |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1998-2357 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997901751 Country of ref document: EP |